CoChat

A Review of Scientific Ethics Issues Associated with the Recently Approved Drugs for Alzheimer’s Disease

Yeo-Teh, Nicole Shu Ling, Tang, Bor Luen · 2023 · Science and Engineering Ethics

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Alzheimer's disease (AD), the devastating and most prevailing underlying cause for age-associated dementia, has no effective disease-modifying treatment. The last approved drug for the relief of AD symptoms was in 2003. The recent approval of sodium oligomannate (GV-971, 2019) in China and the human antibody aducanumab in the USA (ADUHELM, 2021) therefore represent significant breakthroughs, albeit ones that are fraught with controversy. Here, we explore potential scientific ethics issues associated with GV-971 and aducanumab's development and approval. While these issues may be belied by socioeconomic and political complexities in the heady business of commercial drug development, they are of fundamental importance to scientific integrity and ultimately, welfare of patients. We posit that the push for approval of both AD drugs based on incomplete research and unconvincing marginal effectiveness is ethically unsound. Regardless of how both these drugs shall perform in the market for the years to come, the scientific ethics issues and potentially questionable research practices should therefore be duly noted and lessons learned.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11948-022-00422-0

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 49 references

Cited by

See all 28

Metadata

Authors
Yeo-Teh, N. S. L., & Tang, B. L.
Affiliations
National University of Singapore (SG)
Corresponding author
  • Yeo-Teh, Nicole Shu Ling
  • Tang, Bor Luen
Venue
Science and Engineering Ethics
Published
2023-01-10
Volume
29
Issue
1
Pages
2-2
ISSN
  • 1353-3452 (ISSN-L)
  • 1471-5546
OpenAlex
W4315436196
Cited by
28
References
49
Citations by year
2026: 7 · 2025: 3 · 2024: 9 · 2023: 9
FWCI
4.95
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Science and Engineering Ethics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
  • Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
Keywords
Alzheimer's disease, scientific ethics, drug approval, aducanumab, ADEME, questionable research practices, scientific integrity, drug development, dementia treatment
MeSH terms
Alzheimer Disease, China, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Review of Scientific Ethics Issues Associated with the Recently Approved Drugs for Alzheimer’s Disease. https://app.cochat.ai/papers/10.1007/s11948-022-00422-0
The paper
Yeo-Teh, N. S. L., & Tang, B. L. (2023). A Review of Scientific Ethics Issues Associated with the Recently Approved Drugs for Alzheimer’s Disease. Science and Engineering Ethics. https://doi.org/10.1007/s11948-022-00422-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.